
Oklo, NuScale Power, Centrus Energy, BWX Technologies, Nano Nuclear Energy, Karyopharm Therapeutics, and Lightbridge are the seven Nuclear stocks to watch today, according to MarketBeat’s stock screener tool. “Nuclear stocks” are shares of companies that participate in the nuclear industry — for example, uranium miners, fuel-cycle firms, reactor and component manufacturers, engineering and maintenance contractors, and waste-management businesses. These equities are influenced strongly by government policy, regulation, energy demand, technological developments, and geopolitical factors. Because the sector is capital‑intensive and sensitive to public perception and regulatory shifts, nuclear stocks can show pronounced volatility and long investment horizons. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.
Oklo (OKLO)
Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.
NuScale Power (SMR)
NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.
Read Our Latest Research Report on SMR
Centrus Energy (LEU)
Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.
Read Our Latest Research Report on LEU
BWX Technologies (BWXT)
BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.
Read Our Latest Research Report on BWXT
Nano Nuclear Energy (NNE)
Read Our Latest Research Report on NNE
Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).
Read Our Latest Research Report on KPTI
Lightbridge (LTBR)
Read Our Latest Research Report on LTBR
Featured Stories
- MarketBeat’s Top Five Stocks to Own in February 2026
- Amid the “SaaS Apocalypse”, These 3 Names Are Boosting Buybacks
- 5 Software Stocks That Look Too Cheap to Ignore
- NVIDIA Analysts Say Buy Ahead of Q4 Earnings, With Conviction
- One of the Top Performing ETFs of 2026 So Far May Surprise You
- Alphabet’s Pullback: A Second Chance for Long-Term Investors?
